Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Clare Bailey
Observed name:
Bailey, Clare
Institutions:
University Hospitals Bristol NHS Foundation Trust,
Bristol Eye Hospital,
University Hospitals Bristol and Weston NHS Foundation Trust,
Bristol NHS Foundation Trust
Observed institutions:
University Hospitals Bristol NHS Foundation Trust,
Bristol Eye Hospital,
University Hospitals Bristol and Weston NHS Foundation Trust,
Bristol NHS Foundation Trust
ORCID:
0000-0003-2141-4512
Observed ORCID:
0000-0003-2141-4512
OpenAlex ID:
A5128719467
Pharmacological principles of intravitreal drug therapy and their implications for clinical practice: a primer for the ophthalmologist
2026
·
Samia Ezzine
, Richard Gale
, et al.
·
Eye
·
6
PDF
Real-world treatment patterns and visual outcomes of faricimab in patients with neovascular age-related macular degeneration in the UK at 12 months: the FARWIDE-nAMD study
2026
·
James Talks
, Gabriella de Salvo
, et al.
·
Eye
·
3
PDF
SPECTRUM: Early clinical experience from the first global real-world study of aflibercept 8 mg in patients with diabetic macular oedema
2026
·
Clare Bailey
, Marion R. Munk
, et al.
·
Eye
·
1
PDF
Eighteen-month real-world outcomes of intravitreal aflibercept 8 mg in treatment-naïve neovascular age-related macular degeneration: a UK single-centre experience
2026
·
Benjamin Scrivens
, Pierluigi Daniele
, et al.
·
Graefe s Archive for Clinical and Experimental Ophthalmology
PDF
Response to: ‘Comment on: ‘Pharmacological principles of intravitreal drug therapy and their implications for clinical practice: a primer for the ophthalmologist”
2026
·
Samia Ezzine
, Richard Gale
, et al.
·
Eye
Enhanced Macular Imaging Referral Pathway: Bridging Community Optometrists and Hospital Specialists for Smarter Eye Care
2026
·
Serena Salvatore
, Josh Harvey
, et al.
·
Ophthalmology and Therapy
PDF
Modified Delphi expert consensus on the optimal intravitreal treatment pathway for centre-involving diabetic macular oedema patients within the National Health Service
2026
·
Richard Gale
, Clare Bailey
, et al.
·
BMJ Open Ophthalmology
SPECTRUM: Week 24 data for aflibercept 8 mg indicate improvements in patients with treatment-naïve nAMD and stable outcomes in patients with previously treated nAMD
2026
·
Stahl, Andreas
, Lange, Clemens
, et al.
·
German Medical Science (German Research Foundation)
Infographic: SPECTRUM: study design of the global real-world study of aflibercept 8 mg in the treatment of neovascular age-related macular degeneration and diabetic macular edema
2026
·
Clemens Lange
, Marion R. Munk
, et al.
·
Newcastle University ePrints (Newcastle Univesity)
Show more works
View as search
Works count:
11
Citation count:
10
H-index:
2
I10-index:
Year
Topic
Type